← Latest papers
🧬 genetics

Cortisol homeostasis and glucocorticoid signaling are altered in FMR1 full mutation and premutation carriers.

This study demonstrates that FMR1 full mutation and premutation carriers exhibit altered cortisol homeostasis and glucocorticoid signaling characterized by elevated cortisol levels, reduced NR3C1 expression, increased FKBP5 expression, and hypermethylation of the NR3C1 promoter, suggesting that expanded CGG repeats directly contribute to stress-axis dysfunction in fragile X-associated disorders.

Original authors: Mushtaq, H., Reshi, M. M., Hussain, S. K., Hafiz, A., Qurashi, A.

Published 2026-10-24
📖 6 min read🧠 Deep dive

Original authors: Mushtaq, H., Reshi, M. M., Hussain, S. K., Hafiz, A., Qurashi, A.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The human body possesses a sophisticated internal alarm system designed to handle stress. When faced with a challenge, a chain reaction begins in the brain, signaling the adrenal glands to release a hormone called cortisol. This chemical acts as a master regulator, helping the body manage energy, control inflammation, and keep the mind alert. Crucially, this system has a built-in off-switch: once cortisol levels rise high enough, it signals the brain to stop producing more, preventing the body from staying in a state of high alert indefinitely. This delicate balance is known as homeostasis. When this system malfunctions, the body may remain flooded with stress hormones, leading to long-term health issues. While scientists have long understood how this system works in healthy people, they have been less clear on how it behaves in individuals with specific genetic conditions that affect the brain and nervous system.

One such condition is Fragile X syndrome, a common inherited cause of intellectual disability and autism. It is caused by a specific error in a gene called FMR1, where a tiny segment of DNA repeats itself too many times. In severe cases, this repetition is so large that the gene shuts down completely, stopping the production of a vital protein. In milder cases, the gene remains active but produces too much of the genetic message, which can be toxic to cells. These genetic variations create a spectrum of disorders, ranging from the severe intellectual disability of Fragile X syndrome to a condition in older adults called FXTAS, which causes tremors and balance problems. For years, researchers have known that people with these conditions often struggle with anxiety and emotional regulation, but the biological link between their genetic error and their stress response has remained a mystery.

A team of researchers in India recently set out to solve this puzzle by looking directly at the stress hormone system in people carrying these genetic variations. They began by screening a large group of nearly 900 individuals who had been referred to clinics for suspected Fragile X-related issues. From this group, they identified a small but significant number of people who carried the genetic error: ten individuals with the severe full mutation and ten with the milder premutation. The scientists then compared these twenty carriers against a group of healthy people without the genetic error. They measured the amount of cortisol in the blood, examined the activity of genes that control how cells respond to cortisol, and looked at the chemical tags on DNA that can turn genes on or off.

The results revealed a clear and consistent pattern of disruption. The researchers found that individuals with the genetic error had significantly higher levels of cortisol in their blood compared to the healthy controls. This elevation was not just a temporary reaction to the stress of a medical visit; it was a persistent state of high alert. To understand why the body was producing so much cortisol, the team looked at the genes responsible for managing it. They discovered that the gene for the cortisol receptor—the part of the cell that listens for the hormone's signal—was less active in the carriers. At the same time, another gene that acts as a brake on the receptor's function was overly active. It is as if the radio receiver in the cell was turned down while the volume control was stuck on high, making it difficult for the body to hear the "stop" signal and shut off the stress response.

Further investigation showed that the gene for the cortisol receptor was chemically silenced, a process known as methylation, which prevents it from working properly. This epigenetic change was more common in the carriers than in the healthy group. The researchers also found that these changes were not limited to the severe form of the condition; even those with the milder premutation showed the same pattern of high cortisol and altered gene activity. This suggests that the stress system is disturbed early in the genetic spectrum and persists as the condition progresses. The study also noted that these differences became more pronounced as the carriers got older, hinting that the stress system may become increasingly unstable over time.

To confirm that the genetic error itself was the direct cause of these changes, rather than just a side effect of living with a chronic illness, the scientists turned to a laboratory model. They grew human cells in a dish and introduced the expanded DNA repeats found in the patients. Even without the complexity of a whole human body, these cells began to behave like those of the patients: they showed reduced levels of the cortisol receptor and increased levels of the braking gene. When the researchers added a synthetic stress hormone to the cells, the cells with the expanded repeats reacted differently than normal cells, struggling to regulate their response. This experiment proved that the expanded DNA repeats are sufficient on their own to disrupt the stress signaling pathway.

The study also addressed a common question: could these high stress levels simply be the result of a difficult life or chronic anxiety? The researchers carefully surveyed the participants about their daily stressors, sleep, and family environment. They found that the groups with the genetic error did not report higher levels of external stress than the healthy group. This suggests that the elevated cortisol and the altered gene activity are intrinsic to the genetic condition itself, arising from the biology of the mutation rather than the environment.

While the study involved a relatively small number of participants and the researchers caution that larger studies are needed to confirm these findings, the evidence points to a new understanding of Fragile X-related disorders. The work suggests that the genetic error does more than just affect the brain's development; it fundamentally rewires the body's stress management system. By identifying this specific breakdown in the cortisol pathway, the research opens a door for future investigations into how to support the stress response in these individuals, potentially offering new ways to manage the anxiety and emotional challenges that often accompany these conditions.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →